Malta vs Small states: Cause of death, by non-communicable diseases, female
Malta
84.5%
in 2021
Small states
68.6%
in 2021
Malta rank
19th
Small states rank
19th
Cause of death, by non-communicable diseases, female over time
- Malta
- Small states
How they compare
Malta currently reports 84.5% against 68.6% in Small states, a difference of 15.9%.
That makes Malta's figure about 1.2 times Small states's.
Across all 6 years both countries report, Malta has been ahead every year.
Malta ranks 19th and Small states ranks 19th of 185 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malta | Small states | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.2% | 66.0% | 23.1% | Malta |
| 2010s | 90.4% | 74.7% | 15.7% | Malta |
| 2020s | 85.0% | 72.4% | 12.7% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Malta or Small states?
- Malta, at 84.5% against 68.6% in Small states as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Malta and Small states?
- 15.9%, with Malta ahead.
- How many years of comparable data are there for Malta and Small states?
- 6 years are reported by both, from 2000 to 2021.
- How do Malta and Small states rank globally for cause of death, by non-communicable diseases, female?
- Malta ranks 19th and Small states ranks 19th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.